Clinical Trial Results: XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial results for XB2001 in combination with ONIVYDE and 5-FU/LV (with or without folinic acid) in advanced pancreatic cancer have been completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-FU/LV (5-fluorouracil with leucovorin)
• Onivyde (irinotecan hydrochloride liposome injection)
• XB2001

Snippet

Sponsor: XBiotech, Inc. | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-08-04